CLOVER HEALTH INVESTMENTS, CORP. /DE Deferred Tax Assets, Valuation Allowance
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) had Deferred Tax Assets, Valuation Allowance of $408.00 million as of 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsValuationAllowance · last filed 2026-02-27
- 2025-12-31: Deferred Tax Assets, Valuation Allowance $408.00M.
- 2024-12-31: Deferred Tax Assets, Valuation Allowance $400.81M.
- 2023-12-31: Deferred Tax Assets, Valuation Allowance $396.91M.
- 2022-12-31: Deferred Tax Assets, Valuation Allowance $369.53M.
| Period end | Deferred Tax Assets, Valuation Allowance |
|---|---|
| 2025-12-31 | $408.00M 10-K · filed 2026-02-27 |
| 2024-12-31 | $400.81M 10-K · filed 2026-02-27 |
| 2023-12-31 | $396.91M 10-K · filed 2025-03-03 |
| 2022-12-31 | $369.53M 10-K · filed 2024-03-14 |
| 2021-12-31 | $275.87M 10-K · filed 2023-03-01 |
| 2020-12-31 | $163.20M 10-K · filed 2022-02-28 |